LifeMD achieved an outstanding first quarter, with total revenues increasing 49% year-over-year to $65.7 million and telehealth revenue up 70%. The company reported its first-ever quarter of positive GAAP net income of $0.6 million, or $0.01 per diluted share, and significantly raised its full-year 2025 guidance.
LifeMD achieved record quarterly revenue and adjusted EBITDA in Q4 2024, with consolidated revenue increasing 43% year-over-year to $64.3 million and adjusted EBITDA increasing 78% to $9.0 million. The telehealth segment was a key driver, with revenue up 60% and adjusted EBITDA up 396%.
LifeMD reported a 323% increase in revenue to $18.2 million for Q1 2021. The company also raised its full-year revenue guidance to $90-$100 million, reflecting strong growth and recurring subscription revenue.
LifeMD reported a significant increase in revenue for Q4 2020, reaching a record $12.9 million, a 227% increase compared to the same period last year. This growth was primarily driven by a substantial increase in telemedicine product revenues. The company is forecasting revenue to range between $85 million and $95 million for the full year 2021.